SCHEMBL5445836

SCHEMBL5445836

COc1ccc(N(N=O)c2cccc(C(=O)O)c2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 3/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
MRGPRX4 Q96LA9 2/20 0.50
TP53 P04637 1/20 0.50
PKM P14618 1/20 0.50
NFKB1 P19838 1/20 0.50
NFKB2 Q00653 1/20 0.50
RELA Q04206 1/20 0.50
RXFP1 Q9HBX9 1/20 0.50
CA1 P00915 1/20 0.47
CA2 P00918 1/20 0.47
KDM4E B2RXH2 2/20 0.45
HPGD P15428 1/20 0.44
KMT2A Q03164 4/20 0.44
NPC1 O15118 2/20 0.44
MEN1 O00255 2/20 0.44
CES2 O00748 1/20 0.44
CES1 P23141 1/20 0.44
MITF O75030 1/20 0.44
MEP1A Q16819 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5454597 0.90 RAB9A (0.51) RAB9ASMN1; SMN2MRGPRX4TP53PKM
SCHEMBL5445817 0.85 CA1 (0.67) RAB9ASMN1; SMN2CA1CA2KDM4E
SCHEMBL5450787 0.83 ALDH1A1 (0.46) RAB9ASMN1; SMN2MRGPRX4CA1CA2
SCHEMBL11421759 0.82 ALDH1A1 (0.65) CA1CA2KDM4EHPGDKMT2A
SCHEMBL5447510 0.81 ALDH1A1 (0.47) MRGPRX4CA1CA2HPGDKMT2A
SCHEMBL29933468 0.78 CA1 (0.50) RAB9ASMN1; SMN2TP53PKMCA1
SCHEMBL5440611 0.77 ALDH1A1 (0.46) CA1CA2KMT2ANPC1MEN1
SCHEMBL7565624 0.77 RAB9A (0.52) RAB9ASMN1; SMN2MRGPRX4TP53PKM
SCHEMBL5928569 0.77 RAB9A (0.49) RAB9ASMN1; SMN2MRGPRX4TP53PKM
SCHEMBL6354659 0.76 ALDH1A1 (0.65) RAB9ASMN1; SMN2PKMKDM4EKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070123586-A1 Nitroso derivatives of diphenylamine MERCK PATENT GMBH (DE) 2007-05-31 US claimed
EP-1687260-A1 NITROSO DERIVATIVES OF DIPHENYLAMINE MERCK PATENT GmbH (DE) 2006-08-09 EP claimed
WO-2005051896-A1 NITROSO DERIVATIVES OF DIPHENYLAMINE MERCK PATENT GMBH (DE) 2005-06-09 WO claimed
US-20070123586-A1 Nitroso derivatives of diphenylamine MERCK PATENT GMBH (DE) 2007-05-31 US disclosed
US-20070123586-A1 Nitroso derivatives of diphenylamine MERCK PATENT GMBH (DE) 2007-05-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070123586-A1 Nitroso derivatives of diphenylamine NOS3, CBR3, CBR1 RAB9A 3830/4885SMN1; SMN2 1787/4885MRGPRX4 3469/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.